Sequencing data on patients with Sezary Syndrome
This dataset consists of sequencing data on 15 patients with Sezary syndrome. On 12 of these patients, we have exome sequencing data while on 10 patients, we have RNA sequencing data. In total for seven patients, we have both exome as well as RNA sequencing data. We looked for gene mutations and fusion events in these patients to identify genes that could be involved in the pathogenesis of the disease.
- 13/04/2016
- 30 samples
- DAC: EGAC00001000438
- Technologies: Illumina HiSeq 2000, Illumina HiSeq 2500
Policy for Sezary project data access
In assigning this agreement:1.You agree to use the Data only for scientific purposes according to the consent obtained from patients.2.You agree not to use the data or any part thereof for sale or for any commercial purpose.3.You agree to preserve, at all times, the confidentiality of information and Data pertaining to Data Subjects. In particular, you undertake not to use, or attempt to use the Data to compromise the confidentiality of information on Data Subjects and their right to privacy.4.You agree not to transfer or disclose the Data, on whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or Programme management. If you wish to share the Data with a collaborator, that third party must make a separate application for access to the data.5.You agree to use the Data for the approved purpose and project described in your application; use of the Data for a new purpose or project will require a new application and approval.6.You agree to acknowledge in any work based in whole or part on the Data, the published paper from which the Data derives.7.You accept and agree that the Centre for Genomic Regulation (Barcelona, Spain), the original Data creators, depositors or copyright holders and the funders of the Data or any part of the Data supplied:a.Bear no legal responsibility for the accuracy or comprehensiveness of the Data, andb.Will not be liable for direct, indirect, consequential, or incidental damages or losses arising from use of the Data, or from the unavailability of, or break in access to, the Data for whatever reason.8.You understand and acknowledge that the Data is protected by copyright and other intellectual property rights, and that duplication, except as reasonably required to carry out Your research with the Data, or sale of all or part of the Data on any media is not permitted.9.You recognize that nothing in this agreement shall operate to transfer to the User Institution any intellectual property rights relating to the Data. The User Institution has the right to develop intellectual property based on comparisons with its own data.10.You accept that upon any breach of this agreement by You, this agreement will terminate immediately and You will be required to destroy any Data held.11.You accept that it may be necessary to alter the terms of this agreement in order to address new concerns. In this case, the appointed agent will contact You to inform You of any changes and You agree that Your continued use of the Data shall be dependent on the parties entering into a new version of the Agreement.12.You agree that on completion of the agreed purpose, if requested, you will submit a report to the Data Access Committee. The Data Access Committee agrees to treat the report and all information, data, results and conclusions contained within such report as confidential information belonging to the User Institution.13.You accept that the Data are protected by and subject to international laws and that You are responsible for ensuring compliance with any such applicable law. The Data Access Committee at the Centre for Genomic Regulation, reserve the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures.14.This agreement shall be construed, interpreted and governed by the laws of Spain and shall be subject to the non-exclusive jurisdiction of the courts of that jurisdiction.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001001706 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.